HGHCX Mutual Fund

NAV$26.77

Fund Essentials - as of Jan 31, 2026

Net Assets
$16M
Expense Ratio
2.07%
Dividend Yield (Current)
5.25%
Holdings
84
Inception Date
May 1, 2000
Fund Family
Hartford Funds
Investment Style
••••••••••
Asset Class
••••••••••
Legal Structure
••••••••••
Dividend Frequency
Annually

Performance

YTD+4.62%
1 Year+34.10%
3 Year+8.48%
5 Year+5.81%
10 Year+14.01%

Asset Allocation

Stocks: 99.68%
Bonds: 0.19%
Cash: 0.14%

Top Holdings

View All →
TickerNameWeight
LLYEli Lilly & Co13.12%
MRKMerck & Company Inc5.74%
JNJJohnson & Johnson5.07%
UNHUnitedhealth Group Incorporated4.64%
ABBVAbbvie Inc3.84%
Top 10 Concentration: 47.48%Report Date: Jan 31, 2026
Download all 84 holdings for HGHCX
CSV export with sector, industry & share changes
Get CSV

Dividend Summary

View Details →
Dividend Yield (Current)
5.25%
Frequency
Annually

Peer Comparison

Benchmark
••••••••••
Outperforming by ••••%
Ranked #••• of •,••• funds
This Mutual Fund
+••.••%
Peer Avg
+••.••%
Premium Feature
Sign in to unlock peer comparison, category rankings and more

HGHCX Mutual Fund Overview

HGHCX Mutual Fund (The Hartford Healthcare Fund Class C) is managed by Hartford Funds with $15.8M in net assets. HGHCX expense ratio is 2.07%, holding 84 positions across sectors including Health Care, Unknown, Financials. Inception date: 2000-05-01.

HGHCX performance shows a YTD return of 4.62%. The 1-year return is 34.10% and the 5-year return is 5.81%. HGHCX dividend yield stands at 5.25%, paid annually.

HGHCX top holdings include Eli Lilly & Co (13.1%), Merck & Company Inc (5.7%), Johnson & Johnson (5.1%), Unitedhealth Group Incorporated (4.6%), Abbvie Inc (3.8%). View all HGHCX holdings, sector breakdown, or dividend history.

HGHCX can be compared against other funds using the overlap calculator or side-by-side comparison tool. HGHCX alternatives are available via the screener, along with tax-loss harvesting opportunities.